Detalles de la búsqueda
1.
Survival with Cemiplimab in Recurrent Cervical Cancer.
N Engl J Med
; 386(6): 544-555, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139273
2.
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Gynecol Oncol
; 178: 119-129, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862791
3.
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(4): 465-478, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298906
4.
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.
Lancet Oncol
; 22(5): 632-642, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862001
5.
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1721-1731, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715071
6.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743851
7.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 379(26): 2495-2505, 2018 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345884
8.
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.
Gynecol Oncol
; 163(1): 41-49, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353615
9.
Heterotopic transplantation of cryopreserved ovarian tissue in cancer patients: a case series.
Gynecol Endocrinol
; 35(12): 1043-1049, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31373236
10.
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.
Int J Gynecol Cancer
; 28(8): 1498-1506, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30247247
11.
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.
Invest New Drugs
; 33(6): 1232-41, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553306
12.
Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer.
Gynecol Oncol
; 138(1): 18-23, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925990
13.
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.
J Clin Oncol
; 41(3): 609-617, 2023 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082969
14.
Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.
Hum Reprod Update
; 28(3): 400-416, 2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35199164
15.
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Eur J Cancer
; 174: 299-309, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922251
16.
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial.
J Clin Oncol
; 38(30): 3528-3537, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749942
17.
Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer.
Clin Cancer Res
; 25(5): 1472-1478, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563934
18.
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.
J Geriatr Oncol
; 8(1): 56-63, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27889278
19.
Correction to: Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.
Hum Reprod Update
; 28(3): 455, 2022 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285901
20.
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
J Clin Oncol
; 28(19): 3107-14, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20516432
Resultados
1 -
20
de 20
1
Próxima >
>>